Jazz Pharmaceuticals plc Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1.07B | 1.20B | 1.13B | 1.05B | 897.8M | 1.09B | 1.05B | 1.02B |
| Cost of Goods Sold | 306.4M | 24.6M | 257.8M | 116.3M | 104.6M | 128.7M | 111.6M | 109.9M |
| Gross Profit | 762.5M | 1.17B | 868.3M | 929.4M | 793.2M | 959.5M | 943.4M | 913.9M |
| R&D Expenses | 134.1M | 171.4M | 240.7M | 190.0M | 180.7M | 240.5M | 199.9M | 220.7M |
| Operating Expenses | 548.7M | 264.1M | 810.8M | 1.62B | 849.1M | 768.7M | 683.1M | 714.5M |
| Operating Income | 213.8M | 909.2M | 57.5M | -686.4M | -55.9M | 190.8M | 260.2M | 199.4M |
| Other Income / Gains | 85.4M | -700.9M | -48.5M | -49.2M | -54.5M | -57.6M | -59.7M | -61.5M |
| Net Income | 293.1M | 203.5M | 251.4M | -718.5M | -92.5M | 191.1M | 215.1M | 168.6M |
| EPS (Diluted) | 4.73 | 3.28 | 4.14 | -11.74 | -1.52 | 3.16 | 3.50 | 2.68 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.713 | 0.979 | 0.771 | 0.889 | 0.883 | 0.882 | 0.894 | 0.893 |
| General And Administrative Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 352.7M | 406.2M | 530.6M | 358.4M | 514.0M | 369.3M | 325.8M | 338.5M |
| Other Expenses | 61.9M | -313.5M | 39.5M | 1.07B | 154.4M | 158.9M | 157.5M | 155.2M |
| Cost And Expenses | 855.1M | 288.7M | 1.07B | 1.73B | 953.7M | 897.4M | 794.8M | 824.4M |
| Interest Income | 23.4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 63.3M | 45.4M | 48.6M | 47.4M | 53.7M | 51.3M | 58.7M | 62.0M |
| Depreciation And Amortization | 181.4M | 24.9M | 178.2M | 174.0M | 164.9M | 168.4M | 165.2M | 163.0M |
| Ebitda | 543.9M | 278.6M | 235.9M | -514.2M | 138.9M | 397.0M | 424.5M | 363.0M |
| Ebitdaratio | 0.509 | 0.233 | 0.209 | -0.492 | 0.155 | 0.365 | 0.402 | 0.355 |
| Operating Income Ratio | 0.20 | 0.759 | 0.051 | -0.656 | -0.062 | 0.175 | 0.247 | 0.195 |
| Income Before Tax | 299.2M | 208.3M | 9.0M | -735.6M | -110.4M | 133.2M | 200.5M | 137.9M |
| Income Before Tax Ratio | 0.28 | 0.174 | 0.008 | -0.703 | -0.123 | 0.122 | 0.19 | 0.135 |
| Income Tax Expense | 6.1M | 4.9M | -242.4M | -17.1M | -17.8M | -57.9M | -14.5M | -30.7M |
| Net Income Ratio | 0.274 | 0.17 | 0.223 | -0.687 | -0.103 | 0.176 | 0.204 | 0.165 |
| Epsdiluted | 4.43 | 3.34 | 4.08 | -11.74 | -1.52 | 3.11 | 3.42 | 2.49 |
| Weighted Average Shs Out | 61.9M | 61.0M | 60.7M | 61.2M | 61.0M | 60.5M | 61.4M | 62.9M |
| Weighted Average Shs Out Dil | 66.1M | 61.0M | 61.6M | 61.2M | 61.0M | 61.5M | 63.2M | 69.6M |